Oleinika K, Mauri C, Salama AD. Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol. 2019;15(1):11–26.
Article
CAS
PubMed
Google Scholar
Rincon-Arevalo H, Sanchez-Parra CC, Castano D, et al. Regulatory B cells and mechanisms. Int Rev Immunol. 2016;35(2):156–76.
CAS
PubMed
Google Scholar
Vossenkamper A, Blair PA, Safinia N, et al. A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. J Exp Med. 2013;210(9):1665–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Loder F, Mutschler B, Ray RJ, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med. 1999;190(1):75–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sims GP, Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127(1):14–25.
Article
CAS
PubMed
Google Scholar
Agrawal S, Smith SA, Tangye SG, et al. Transitional B cell subsets in human bone marrow. Clin Exp Immunol. 2013;174(1):53–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Simon Q, Pers JO, Cornec D, et al. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy Clin Immunol. 2016;137(5):1577–1584.e10.
Article
CAS
PubMed
Google Scholar
Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179–91.
Article
PubMed
Google Scholar
van Zelm MC, Szczepanski T, van der Burg M, et al. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204(3):645–55.
Article
PubMed
PubMed Central
CAS
Google Scholar
Blair PA, Norena LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129–40.
Article
CAS
PubMed
Google Scholar
Carvajal Alegria G, Gazeau P, Hillion S, et al. Could lymphocyte profiling be useful to diagnose systemic autoimmune diseases? Clin Rev Allergy Immunol. 2017;53(2):219–36.
Article
CAS
PubMed
Google Scholar
Taher TE, Ong VH, Bystrom J, et al. Association of defective regulation of autoreactive interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis. Arthr Rheumatol. 2018;70(3):450–61.
Article
CAS
Google Scholar
Piper CJM, Wilkinson MGL, Deakin CT, et al. CD19(+)CD24(hi)CD38(hi) B cells are expanded in juvenile dermatomyositis and exhibit a pro-inflammatory phenotype after activation through toll-like receptor 7 and interferon-alpha. Front Immunol. 2018;9:1372.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lee-Chang C, Top I, Zephir H, et al. Primed status of transitional B cells associated with their presence in the cerebrospinal fluid in early phases of multiple sclerosis. Clin Immunol. 2011;139(1):12–20.
Article
CAS
PubMed
Google Scholar
Quan C, Yu H, Qiao J, et al. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Mult Scler. 2013;19(3):289–98.
Article
CAS
PubMed
Google Scholar
Cagigi A, Palma P, Nilsson A, et al. The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children. AIDS. 2010;24(13):2075–80.
Article
CAS
PubMed
Google Scholar
Holz LE, Yoon JC, Raghuraman S, et al. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naive B cell apoptosis. Hepatology. 2012;56(5):1602–10.
Article
CAS
PubMed
Google Scholar
Bockstal V, Guirnalda P, Caljon G, et al. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis. PLoS Pathog. 2011;7(6):e1002089.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sandel PC, Monroe JG. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity. 1999;10(3):289–99.
Article
CAS
PubMed
Google Scholar
Allman D, Srivastava B, Lindsley RC. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol Rev. 2004;197:147–60.
Article
CAS
PubMed
Google Scholar
Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595–621.
Article
CAS
PubMed
Google Scholar
Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol. 2002;168(5):2101–10.
Article
CAS
PubMed
Google Scholar
Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–16.
Article
CAS
PubMed
Google Scholar
Henderson RB, Grys K, Vehlow A, et al. A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival. J Exp Med. 2010;207(4):837–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Petro JB, Gerstein RM, Lowe J, et al. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem. 2002;277(50):48009–19.
Article
CAS
PubMed
Google Scholar
Hamilton JA, Hsu HC, Mountz JD. Autoreactive B cells in SLE, villains or innocent bystanders? Immunol Rev. 2019;292:120–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24(6):342–8.
Article
CAS
Google Scholar
Benitez A, Weldon AJ, Tatosyan L, et al. Differences in mouse and human nonmemory B cell pools. J Immunol. 2014;192(10):4610–9.
Article
CAS
PubMed
Google Scholar
Allman D, Lindsley RC, Demuth W, et al. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001;167(12):6834–40.
Article
CAS
PubMed
Google Scholar
Saijo K, Schmedt C, Su IH, et al. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development. Nat Immunol. 2003;4(3):274–9.
Article
CAS
PubMed
Google Scholar
Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2(12):945–56.
Article
CAS
PubMed
Google Scholar
Huttl S, Klasener K, Schweizer M, et al. Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells. J Immunol. 2015;195(4):1548–63.
Article
PubMed
CAS
Google Scholar
Sasaki Y, Casola S, Kutok JL, et al. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol. 2004;173(4):2245–52.
Article
CAS
PubMed
Google Scholar
Gross JA, Dillon SR, Mudri S, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15(2):289–302.
Article
CAS
PubMed
Google Scholar
Rowland SL, Leahy KF, Halverson R, et al. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J Immunol. 2010;185(8):4570–81.
Article
CAS
PubMed
Google Scholar
Tussiwand R, Rauch M, Fluck LA, et al. BAFF-R expression correlates with positive selection of immature B cells. Eur J Immunol. 2012;42(1):206–16.
Article
CAS
PubMed
Google Scholar
Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med. 1995;181(6):2129–40.
Article
CAS
PubMed
Google Scholar
Wang H, Feng J, Qi CF, et al. Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection. J Immunol. 2007;179(11):7544–52.
Article
CAS
PubMed
Google Scholar
Wang H, Clarke SH. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J Immunol. 2003;171(12):6381–8.
Article
CAS
PubMed
Google Scholar
Stadanlick JE, Cancro MP. BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol. 2008;20(2):158–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zikherman J, Parameswaran R, Weiss A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature. 2012;489(7414):160–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyer-Bahlburg A, Andrews SF, Yu KO, et al. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med. 2008;205(1):155–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kolhatkar NS, Brahmandam A, Thouvenel CD, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015;212(10):1663–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vossenkamper A, Spencer J. Transitional B cells: how well are the checkpoints for specificity understood? Arch Immunol Ther Exp (Warsz). 2011;59(5):379–84.
Article
Google Scholar
Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131(4):959–71.
Article
CAS
PubMed
Google Scholar
Suryani S, Tangye SG. Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Rev Clin Immunol. 2010;6(5):765–75.
Article
PubMed
Google Scholar
Suryani S, Fulcher DA, Santner-Nanan B, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 2010;115(3):519–29.
Article
CAS
PubMed
Google Scholar
Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374–7.
Article
CAS
PubMed
Google Scholar
Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982–93.
Article
CAS
PubMed
Google Scholar
Cheng Y, Sun L, Xie Z, et al. Diversity of immune cell types in multiple sclerosis and its animal model: pathological and therapeutic implications. J Neurosci Res. 2017;95(10):1973–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Han J, Sun L, Wang Z, et al. Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders. Neurol Sci. 2017;38(7):1205–12.
Article
PubMed
Google Scholar
Han J, Sun L, Fan X, et al. Role of regulatory b cells in neuroimmunologic disorders. J Neurosci Res. 2016;94(8):693–701.
Article
CAS
PubMed
PubMed Central
Google Scholar
Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto M, Baba A, Yokota T, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41(6):1040–51.
Article
CAS
PubMed
Google Scholar
Hasan MM, Thompson-Snipes L, Klintmalm G, et al. CD24(hi)CD38(hi) and CD24(hi)CD27(+) human regulatory B cells display common and distinct functional characteristics. J Immunol. 2019;203(8):2110–20.
Article
CAS
PubMed
Google Scholar
Chung JB, Sater RA, Fields ML, et al. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int Immunol. 2002;14(2):157–66.
Article
CAS
PubMed
Google Scholar
Cuss AK, Avery DT, Cannons JL, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006;176(3):1506–16.
Article
CAS
PubMed
Google Scholar
Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007;178(12):7868–78.
Article
CAS
PubMed
Google Scholar
Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):3420–30.
CAS
PubMed
PubMed Central
Google Scholar
Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569–79.
Article
CAS
PubMed
Google Scholar
Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 2012;14(1):R32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nova-lamperti E, Fanelli G, Becker PD, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+ T-cell responses. Sci Rep. 2016;6:20044.
Article
CAS
PubMed
PubMed Central
Google Scholar
Flores-borja F, Bosma A, Ng D, et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23.
Article
PubMed
CAS
Google Scholar
Bosma A, Abdel-Gadir A, Isenberg DA, et al. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity. 2012;36(3):477–90.
Article
CAS
PubMed
Google Scholar
Khan AR, Hams E, Floudas A, et al. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun. 2015;6:5997.
Article
CAS
PubMed
Google Scholar
Burton H, Dorling A. Transitional B cell subsets-a convincing predictive biomarker for allograft loss? Kidney Int. 2017;91(1):18–20.
Article
CAS
PubMed
Google Scholar
Liu M, Guo Q, Wu C, et al. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol. 2019;16(4):367–79.
Article
CAS
PubMed
Google Scholar
Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lino AC, Dorner T, Bar-Or A, et al. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol Rev. 2016;269(1):130–44.
Article
CAS
PubMed
Google Scholar
Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491–502.
Article
CAS
PubMed
Google Scholar
Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20(4):441–53.
Article
CAS
PubMed
Google Scholar
Cancro MP. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev. 2004;197:89–101.
Article
CAS
PubMed
Google Scholar
Varin MM, le Pottier L, Youinou P, et al. B-cell tolerance breakdown in Sjogren’s syndrome: focus on BAFF. Autoimmun Rev. 2010;9(9):604–8.
Article
CAS
PubMed
Google Scholar
Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293(5537):2111–4.
Article
CAS
PubMed
Google Scholar
Tarique M, Naz H, Kurra SV, et al. Interleukin-10 producing regulatory B cells transformed CD4(+)CD25(−) into tregs and enhanced regulatory T cells function in human leprosy. Front Immunol. 2018;9:1636.
Article
PubMed
PubMed Central
CAS
Google Scholar
Granato A, Hayashi EA, Baptista BJ, et al. IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints. J Immunol. 2014;192(12):5761–75.
Article
CAS
PubMed
Google Scholar
Nelms K, Keegan AD, Zamorano J, et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701–38.
Article
CAS
PubMed
Google Scholar
Mihara M, Hashizume M, Yoshida H, et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122(4):143–59.
Article
CAS
Google Scholar
Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–57.
Article
CAS
PubMed
Google Scholar
Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–8.
Article
CAS
PubMed
Google Scholar
Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells. Nat Immunol. 2007;8(9):942–9.
Article
CAS
PubMed
Google Scholar
Serada S, Fujimoto M, Mihara M, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2008;105(26):9041–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Karnell JL, Rieder SA, Ettinger R, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev. 2018;141:92–103.
Article
PubMed
CAS
Google Scholar
Lemoine S, Morva A, Youinou P, et al. Human T cells induce their own regulation through activation of B cells. J Autoimmun. 2011;36(3–4):228–38.
Article
CAS
PubMed
Google Scholar
Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944–50.
Article
CAS
PubMed
Google Scholar
Qian Y, Qin J, Cui G, et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity. 2004;21(4):575–87.
Article
CAS
PubMed
Google Scholar
Qian Y, Giltiay N, Xiao J, et al. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren’s syndrome. Eur J Immunol. 2008;38(8):2219–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Giltiay NV, Lu Y, Allman D, et al. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol. 2010;185(1):99–109.
Article
CAS
PubMed
Google Scholar
Nasirikenari M, Chandrasekaran EV, Matta KL, et al. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol. 2010;87(3):457–66.
Article
CAS
PubMed
Google Scholar
Nasirikenari M, Segal BH, Ostberg JR, et al. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood. 2006;108(10):3397–405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dougher CWL, Buffone A Jr, Nemeth MJ, et al. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis. J Leukoc Biol. 2017;102(2):507–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Irons EE, Lau JTY. Systemic ST6Gal-1 is a pro-survival factor for murine transitional B cells. Front Immunol. 2018;9:2150.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hennet T, Chui D, Paulson JC, et al. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA. 1998;95(8):4504–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marth JD. Unmasking connections in transmembrane immune signaling. Nat Immunol. 2004;5(10):1008–10.
Article
CAS
PubMed
Google Scholar
Dieudonne Y, Gies V, Guffroy A, et al. Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN. J Autoimmun. 2019;102:150–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Clarke AJ, Ellinghaus U, Cortini A, et al. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Ann Rheum Dis. 2015;74(5):912–20.
Article
PubMed
Google Scholar
Barr TA, Shen P, Brown S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med. 2012;209(5):1001–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Machado-Santos J, Saji E, Troscher AR, et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141(7):2066–82.
Article
PubMed
PubMed Central
Google Scholar
Baker D, Pryce G, Amor S, et al. Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis. Brain. 2018;141(10):2834–47.
Article
PubMed
Google Scholar
Milo R. Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmun Rev. 2016;15(7):714–8.
Article
CAS
PubMed
Google Scholar
D’amico E, Zanghi A, Gastaldi M, et al. Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: present and future perspectives. Autoimmun Rev. 2019;18:665–72.
Article
PubMed
CAS
Google Scholar
Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and Immunotherapy. Neuron. 2018;97(4):742–68.
Article
CAS
PubMed
Google Scholar
Jelcic I, Al Nimer F, Wang J, et al. Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell. 2018;175(1):85–100.e23.
Article
CAS
PubMed
PubMed Central
Google Scholar
von Budingen HC, Bar-Or A, Zamvil SS. B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol. 2011;23(6):713–20.
Article
CAS
Google Scholar
Hausler D, Hausser-Kinzel S, Feldmann L, et al. Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease. Proc Natl Acad Sci USA. 2018;115(39):9773–8.
Article
PubMed
CAS
PubMed Central
Google Scholar
Biragyn A, Aliseychik M, Rogaev E. Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol. 2017;39(3):283–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol. 2018;19(7):696–707.
Article
CAS
PubMed
Google Scholar
Matsushita T, Horikawa M, Iwata Y, et al. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010;185(4):2240–52.
Article
CAS
PubMed
Google Scholar
Giacomini E, Rizzo F, Etna MP, et al. Thymosin-alpha1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients. Mult Scler. 2018;24(2):127–39.
Article
CAS
PubMed
Google Scholar
Miyazaki Y, Niino M, Fukazawa T, et al. Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations. Clin Immunol. 2014;151(2):127–35.
Article
CAS
PubMed
Google Scholar
Yoshizaki A, Miyagaki T, Dilillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ries S, Hilgenberg E, Lampropoulou V, et al. B-type suppression: a role played by “regulatory B cells” or “regulatory plasma cells”? Eur J Immunol. 2014;44(5):1251–7.
Article
CAS
PubMed
Google Scholar
Nielsen CH, Bornsen L, Sellebjerg F, et al. Myelin basic protein-induced production of tumor necrosis factor-alpha and interleukin-6, and presentation of the immunodominant peptide MBP85-99 by B cells from patients with relapsing-remitting multiple sclerosis. PLoS ONE. 2016;11(1):e0146971.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805–15.
Article
CAS
PubMed
Google Scholar
Drori T, Chapman J. Diagnosis and classification of neuromyelitis optica (Devic’s syndrome). Autoimmun Rev. 2014;13(4–5):531–3.
Article
CAS
PubMed
Google Scholar
Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA. 2011;108(9):3701–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010;6(7):383–92.
Article
CAS
PubMed
Google Scholar
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106–12.
Article
CAS
PubMed
Google Scholar
Han J, Yang MG, Zhu J, et al. Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations. Neuropsychiatr Dis Treat. 2017;13:2653–60.
Article
PubMed
PubMed Central
Google Scholar
Wang H, Wang K, Zhong X, et al. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol. 2012;32(5):1007–11.
Article
CAS
PubMed
Google Scholar
Cotzomi E, Stathopoulos P, Lee CS, et al. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production. Brain. 2019;142(6):1598–615.
Article
PubMed
PubMed Central
Google Scholar
Quan C, Zhangbao J, Lu J, et al. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy. J Neuroimmunol. 2015;282:45–53.
Article
CAS
PubMed
Google Scholar
Krumbholz M, Meinl E. B cells in MS and NMO: pathogenesis and therapy. Semin Immunopathol. 2014;36(3):339–50.
Article
CAS
PubMed
Google Scholar